[1]梁雨才.温肾活血汤治疗冠心病心绞痛40例[J].西部中医药,2018,31(04):84-86.
　LIANG Yucai.Kidney-warming Blood-activating Decoction in Treating 40 Cases of Coronary Heart Disease Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2018,31(04):84-86.
点击复制

温肾活血汤治疗冠心病心绞痛40例()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
31
期数:
2018年04期
页码:
84-86
栏目:
出版日期:
2018-04-15

文章信息/Info

Title:
Kidney-warming Blood-activating Decoction in Treating 40 Cases of Coronary Heart Disease Angina Pectoris
文章编号:
1004-6852(2018)04-0084-03
作者:
梁雨才
古浪县中医医院，甘肃 古浪 733103
Author(s):
LIANG Yucai
Gulang County TCM Hospital, Gulang 733103, China
关键词:
冠心病; 心绞痛; 温肾活血汤; 心脏彩超; 内皮细胞功能
Keywords:
coronary heart disease;  angina pectoris;  kidney-warming blood-activating decoction;  cardiac colour Doppler ultrasound;  the functions of endothelial cells
分类号:
R541.4
文献标志码:
B
摘要:
目的：观察温肾活血汤治疗冠心病心绞痛的临床价值。方法：将80例冠心病心绞痛患者按就诊的先后顺序随机分为观察组、对照组各40例，2组患者均行对症支持处理，30 mg/次，3次/d。观察组在对照组治疗的基础上服用温肾活血汤，上药每日1剂，水煎早晚分服。2组均连续治疗2周。比较2组干预后氨基末端脑钠肽前体（NT-proBNP)、基质金属蛋白酶9(MMP-9)、血管内皮素1（ET-1）、一氧化氮（NO）水平，以及左室舒张末期内径(LVEDD)，左室收缩末期内径(LVESD)及左室射血分数(LVEF%)。结果：治疗后观察组NT-proBNP和MMP-9水平均低于对照组，2组间比较差异均有统计学意义(P＜0.05)。治疗后观察组ET-1水平低于对照组，NO水平高于对照组，2组间比较差异均有统计学意义(P＜0.05)。治疗观察组LVEDD和LVESD低于对照组，LVEF%高于对照组，2组间比较差异均有统计学意义(P＜0.05)。结论：针对冠心病心绞痛患者联合使用温肾补血汤治疗，能有效降低心肌损伤，改善心肌功能，延缓心肌重构，提高临床治疗效果。
Abstract:
Objective: To observe clinical values of kidney-warming blood-activating decoction in treating coronary heart disease (CHD) angina pectoris (AP). Methods: Eighty patients were randomized into the observation group and the control group according to the visiting order, 40 cases each group, both groups accepted symptomatic treatment, 30 mg each time, three times each day. Based on the therapy of the control group accepted, the observation group accepted kidney-warming blood-activating decoction orally, one dose each day, water decoction and taking the decoction in the morning and evening. Both groups were treated for two weeks consecutively. The levels of nitric oxide (NO), vascular endothelin-1(ET-1), matrix metalloproteinase-9 (MMP-9) and N-terminal brain natriuretic peptide precursor (NT-proBNP), left ventricular end diastolic diameter (LVEDD), left ventricular end systolic diameter (LVESD) and left ventricular ejection fraction (LVEF%) were compared between both groups after the intervention. Results: The observation group was lower than the control group in the levels of NT-proBNP and MMP-9 after treating, and the difference showed statistical meaning between both groups (P＜0.05). The observation group was lower than the control group in the levels of ET-1 after treating, higher than the control group in the levels of NO, and the difference had statistical meaning (P＜0.05). The observation group was lower than the control group in LVEDD and LVESD after treating, higher than the control group in LVEF%, and the difference was statistically significant (P＜0.05). Conclusion: Treating CHD patients with AP by kidney-warming blood-activating decoction could effectively decrease myocardial damage, improve myocardial function, delay myocardial reconstruction and raise therapeutic effects in clinic

相似文献/References:

[1]马思清 指导：谢春毅.瓜蒌薤白三方防治冠心病的研究现状[J].西部中医药,2012,25(10):118.
　MA Si-qing Director: XIE Chun-yi.Exploration on Three Pieces of GuaLou XieBaiFang in the Prevention of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2012,25(04):118.
[2]马乔娟.银杏叶提取物对绝经后冠心病妇女冠脉血流及血管弹性的影响[J].西部中医药,2013,26(02):24.
　MA Qiaojuan.Effects of Ginaton on Coronary Blood Flow and Vascular Elasticity of Postmenopausal Women with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(04):24.
[3]王龙,王化良.王化良主任巧用经方治疗冠心病合并焦虑状态经验浅析[J].西部中医药,2013,26(03):39.
　WANG Long,WANG Hualiang.Analysis on Director WA NG Hualiang's Experience of Applying Classic Prescriptions to Coronary Heart Disease Complicated to Anxiety[J].Western Journal of Traditional Chinese Medicine,2013,26(04):39.
[4]王鸿燕.丹参酮注射液治疗老年不稳定型心绞痛(心血瘀阻证)50例临床观察[J].西部中医药,2013,26(05):5.
　WANG Hongyan.Observation on DanShenTong Injection in Treating 50 Cases of Senile Unstable Angina Pectoris of Heart Blood Stagnation-obstruction Pattern[J].Western Journal of Traditional Chinese Medicine,2013,26(04):5.
[5]范宗鹏,吴玉姣.穴位埋线联合中药治疗不稳定型心绞痛临床观察[J].西部中医药,2013,26(04):90.
　FAN Zongpeng,WU Yujiao.Clinical Observation on Treatment of Unstable Angina Pectoris with Catgut Embedding at Acupoints and Herbs[J].Western Journal of Traditional Chinese Medicine,2013,26(04):90.
[6]王芳芳.益气活血方对UAP易损斑块相关血清学指标MMP—9、sCD40L、sVCAM—1水平表达的影响[J].西部中医药,2012,25(08):1.
　WANG Fang-fang.Influence of YiQi HuoXueFang on Expressions of Serological Indexes Associated to Vulnerable Plaque of Unstable Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2012,25(04):1.
[7]马丽.冠心病二级预防用药出院带药情况分析[J].西部中医药,2013,26(07):58.
　MA Li.Analysis on Prescribed Medications for Discharged Patients in Secondary Prevention of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(04):58.
[8]潘雪晖.综合护理干预对冠心病患者不良生活方式的影响[J].西部中医药,2013,26(07):105.
　PAN Xuehui.Impact of Comprehensive Nursing Intervention on Lifestyles of Patients with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(04):105.
[9]袁春玲.家庭病床冠心病护理可行性探讨[J].西部中医药,2012,25(07):109.
　YUAN Chun-ling.Probe into Feasibility of Nursing for Patients with Coronary Heart Disease in Family Practice[J].Western Journal of Traditional Chinese Medicine,2012,25(04):109.
[10]董瑞萍.阿昔莫斯胶囊对冠心病PCI术后血液流变学及血脂的调节作用[J].西部中医药,2012,25(05):6.
　DONG Rui-ping.Adjustment of Acipimox Capsule on Hemorheology and Blood Lipid in Patients after PCI[J].Western Journal of Traditional Chinese Medicine,2012,25(04):6.
[11]王凯,林文.丹红与丹参酮ⅡA治疗冠心病心绞痛疗效比较[J].西部中医药,2013,26(08):88.
　WANG Kai,LIN Wen.Comparison between DanHong Injection and Tanshinone ⅡA in Treating Angina Pectoris of Patients with Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(04):88.
[12]王万兰,苏昶才,熊新荣.丹红注射液联合硝酸酯类药物治疗冠心病心绞痛[J].西部中医药,2013,26(12):93.
　WANG Wanlan,SU Changcai,XIONG Xinrong.DanHong Injection Combined with Nitrates in Treating Angina Pectoris of Coronary Heart Disease[J].Western Journal of Traditional Chinese Medicine,2013,26(04):93.
[13]孙文,谢春毅△.丹红注射液治疗冠心病心绞痛临床观察[J].西部中医药,2014,27(03):5.
　SUN Wen,XIE Chunyi.Clinical Observation on DanHong Injection in Treating Coronary Heart Disease Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2014,27(04):5.
[14]张会仲.中西医结合治疗冠心病心绞痛45例[J].西部中医药,2014,27(04):104.
　ZHANG Huizhong.Treatment for 45 Patients Suffering from Coronary Heart Disease Angina Pectoris by Integrative Medicine[J].Western Journal of Traditional Chinese Medicine,2014,27(04):104.
[15]张丽君,赵江花,赵海红,等.心脉疏膏穴位贴敷结合西药治疗冠心病心绞痛 40 例[J].西部中医药,2014,27(09):128.
[16]张红丽,刘海荣△,王媛,等.综合护理对老年冠心病心绞痛患者生活质量的影响[J].西部中医药,2014,27(10):143.
[17]景海涛.丹七活血汤与心痛定片治疗冠心病心绞痛(气滞血瘀型)临床对照研究[J].西部中医药,2016,29(01):110.
　JING Haitao.Clinical Controlled Study on DanQi HuoXue Tang and XinTongDing Tablets in Treating Angina Pectoris of Qi Stagnation and Blood Stasis Pattern[J].Western Journal of Traditional Chinese Medicine,2016,29(04):110.
[18]陈绍琳,段宗强△.补阳还五汤联合参附注射液治疗冠心病心绞痛100例[J].西部中医药,2018,31(12):86.
　CHEN Shaolin,DUAN Zongqiang.BuYang HuanWu Decoction Combined with ShenFu Injection in Treating 100 Cases of Coronary Heart Disease Angina Pectoris[J].Western Journal of Traditional Chinese Medicine,2018,31(04):86.
[19]畅辉,岳黎明△.中西药物联用治疗气阴两虚型冠心病心绞痛75例[J].西部中医药,2019,32(08):98.
　CHANG Hui,YUE Liming.Treating 75 Patients with Coronary Heart Disease Angina Pectoris of Qi-yin Deficiency Pattern by the Combination of Western Medicine and Herbs[J].Western Journal of Traditional Chinese Medicine,2019,32(04):98.
[20]冯晓迪,王东雁△,刘守亮,等.大株红景天注射液与芪苈强心胶囊对冠心病心绞痛患者的影响[J].西部中医药,2020,33(01):106.[doi:10.12174/j.issn.1004-6852.2020.01.28]
　FENG Xiaodi,WANG Dongyan,LIU Shouliang,et al.Effects of Sofren Injection and Qili Qiangxin Capsules on Coronary Heart Disease Angina Pectoris Patients[J].Western Journal of Traditional Chinese Medicine,2020,33(04):106.[doi:10.12174/j.issn.1004-6852.2020.01.28]

备注/Memo

备注/Memo:
收稿日期：2017-11-27 作者简介：梁雨才(1974—)，男，副主任医师。研究方向：心脑血管病的中西医结合治疗。
更新日期/Last Update: 2018-04-15